SKI Market

Indian Indices

Sensex

82,276.07 50.15
( 0.06%)

Global Indices

Nasdaq

49,202.49 377.42
(0.77%)

Dow Jones

6,910.52 51.77
(0.75%)

Hang Seng

58,650.11 1,329.02
(2.32%)

Nikkei 225

10,686.70 1.96
(0.02%)

Forex

USD-INR

90.87 0.15
(0.16%)

EUR-INR

107.26 0.37
(0.35%)

GBP-INR

122.73 0.47
(0.39%)

JPY-INR

0.59 0.00
(0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

99.2482659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

95.14

415216.91

EPS(TTM)

Face Value()

Div & Yield %

18.19

0.92

Back

Alankit standalone net profit rises 77.33% in the September 2025 quarter

Nov 13,2025

Net profit of Alankit rose 77.33% to Rs 3.05 crore in the quarter ended September 2025 as against Rs 1.72 crore during the previous quarter ended September 2024. Sales declined 38.97% to Rs 14.47 crore in the quarter ended September 2025 as against Rs 23.71 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	14.47	23.71	-39
OPM %	10.16	12.48	-
PBDT	5.47	4.12	33
PBT	3.06	2.51	22
NP	3.05	1.72	77

82,276.07 50.15 ( 0.06%)

49,202.49 377.42 (0.77%)

6,910.52 51.77 (0.75%)

58,650.11 1,329.02 (2.32%)

10,686.70 1.96 (0.02%)

90.87 0.15 (0.16%)

107.26 0.37 (0.35%)

122.73 0.47 (0.39%)

0.59 0.00 (0.51%)